Treatment Results of Endoscopic Mucosal Resection with a Ligation Device for Duodenal Neuroendocrine Tumors
Authors:
Open Access
- 15 March 2019
- journal article
- research article
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 58 (6) , 773-777
Abstract
Objective The vertical margin of neuroendocrine tumors (NETs) removed by endoscopic mucosal resection (EMR) is often tumor-positive. We examine the treatment results of endoscopic mucosal resection with a ligation device (EMR-L) for the removal of duodenal NETs located in the submucosal layer without metastasis. EMR-L can be performed with less technical skill, and the ligation device reduces the rate of positive vertical margin. Methods Ten consecutive patients with 10 duodenal NETs resected by EMR-L were enrolled. All of the lesions were located in the submucosal layer, were assessed to be free of metastasis, and were confirmed to be NETs pathologically by an endoscopic biopsy. The endoscopic results, pathological results, and prognosis were all examined. Results The enbloc resection rate and endoscopic complete resection rate were both 100%. Complete resection was achieved pathologically in 7 lesions (70.0%). The vertical margins were negative in all cases. Lymphatic vessel invasion was observed in three patients, all of whom underwent additional surgery with lymph node dissection (one of them also exhibited blood vessel invasion and a positive horizontal margin). No evidence of residual tumors or lymph node metastasis was observed in any of the patients. No recurrence was observed in any of the 10 patients (mean follow-up period: 18.6 months). One patient (10.0%) experienced intraoperative bleeding. Perforation occurred in 1 patient (10.0%), but the condition was managed well by conservative therapy. Conclusion EMR-L was an acceptable method for endoscopically resecting submucosal duodenal NETs, and the NETs resected by EMR-L were tumor-negative in the vertical margins.Keywords
This publication has 18 references indexed in Scilit:
- Endoscopic submucosal resection with a ligation device for the treatment of duodenal neuroendocrine tumorsSurgical Endoscopy, 2015
- Laparoscopic and endoscopic cooperative surgery for duodenal neuroendocrine tumor (NET) G1: Report of a caseInternational Journal of Surgery Case Reports, 2014
- Selection of appropriate endoscopic therapies for duodenal tumors: An open-label study, single-center experienceWorld Journal of Gastroenterology, 2014
- Endoscopic resection for duodenal carcinoid tumors: A multicenter, retrospective studyJournal of Gastroenterology and Hepatology, 2013
- Treatment outcomes according to endoscopic treatment modalities for rectal carcinoid tumorsClinics and Research in Hepatology and Gastroenterology, 2013
- Comparison of Endoscopic Resection Therapies for Rectal Carcinoid TumorJournal of Clinical Gastroenterology, 2013
- Endoscopic mucosal resection with a ligation device or endoscopic submucosal dissection for rectal carcinoid tumors: An analysis of 24 consecutive casesDigestive Endoscopy, 2012
- Endoscopic submucosal dissection (ESD) for gastrointestinal carcinoid tumorsSurgical Endoscopy, 2011
- EFFICACY OF ENDOSCOPIC SUBMUCOSAL RESECTION WITH A LIGATION DEVICE FOR REMOVING SMALL RECTAL CARCINOID TUMOR COMPARED WITH ENDOSCOPIC MUCOSAL RESECTION: ANALYSIS OF 100 CASESDigestive Endoscopy, 2011
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic StratificationNeuroendocrinology, 2008